EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Contact allergy to topical ophthalmic medications: A retrospective single‐centre study of three decades

Sebastian Vigand Svendsen iD, Charlotte G Mortz iD, Kristian Fredløv Mose iD

Contact Dermatitis · 2024

DOI: 10.1111/cod.14552 ↗

At a glance

Journal article in Contact Dermatitis, 2024. Written by Sebastian Vigand Svendsen and 2 co-authors. Institution: Department of Dermatology and Allergy Centre, Odense University Hospital, University of Southern Denmark, Odense, Denmark. Major MEDLINE topics: Dermatitis, Allergic Contact, Ophthalmic Solutions, Patch Tests. Cited 7 times so far (Crossref); 24 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

The prevalence of contact allergy to various ophthalmic medications appears to be rare; however, data on culprits, clinical relevance of sensitizations, and changes in frequency within recent decades are limited.

Objective

This study aimed to investigate the clinical relevance, risk factors, and prevalence of contact allergy to topical ophthalmic medications in patients suspected of allergic contact dermatitis to ophthalmic medication.

Methods

We retrospectively analysed patch test results and clinical data for 754 patients patch‐tested with an ophthalmic medication series at our tertiary referral centre between January 1992 and December 2022.

Results

In total, 37.5% (283/754) of patch‐tested patients had a contact allergy to at least one ophthalmic allergen, with 87.3% (247) being clinically relevant sensitization. Phenylephrine (31.8%, 192/604), povidone‐iodine (29%, 27/93), and tobramycin (23%, 46/200) were the most important sensitizers. The incidence of contact allergies increased significantly in a linear manner ( p = 0.008) from 20% to 44.1% within the study period. Male sex and age above 40 were risk factors for contact allergy to ophthalmic medication.

Conclusions

One third of patch tested patients had allergic contact dermatitis to ophthalmic medication, particularly phenylephrine. Male sex and age above 40 years were independent risk factors and drove the linear increase in contact allergy to ophthalmic medications within the past 31 years.

Subjects

MeSH terms (MEDLINE)

Dermatitis, Allergic ContactOphthalmic SolutionsPatch TestsHumansRetrospective StudiesMaleFemaleAdultMiddle AgedRisk FactorsPrevalenceAgedPhenylephrineSex FactorsYoung AdultAdolescentAge FactorsTobramycin

Author keywords

allergic contact dermatitiscontact allergyeye dropsophthalmicophthalmologictopical eye medications

Substances

Ophthalmic SolutionsPhenylephrineTobramycin

Authors and institutions

  • Department of Dermatology and Allergy Centre, Odense University Hospital, University of Southern Denmark, Odense, Denmark.

ORCID profiles: Sebastian Vigand Svendsen, Charlotte G Mortz, Kristian Fredløv Mose

Cite

APA

Svendsen, S. V., Mortz, C. G., & Mose, K. F. (2024). Contact allergy to topical ophthalmic medications: A retrospective single‐centre study of three decades. Contact Dermatitis. https://doi.org/10.1111/cod.14552

Vancouver

Svendsen SV, Mortz CG, Mose KF. Contact allergy to topical ophthalmic medications: A retrospective single‐centre study of three decades. Contact Dermatitis. 2024. doi:10.1111/cod.14552

BibTeX
@article{Svendsen2024,
  author = {Svendsen, Sebastian Vigand and Mortz, Charlotte G and Mose, Kristian Fredløv},
  title = {Contact allergy to topical ophthalmic medications: A retrospective single‐centre study of three decades},
  journal = {Contact Dermatitis},
  year = {2024},
  doi = {10.1111/cod.14552}
}
Start for free →